Archive | News

Oval Medical expands with two new hires

Monday, 18 July 2011 -The autoinjector development company Oval Medical Technologies ltd, has today announced further expansion with two new appointments of a Programme Manager and a Design Engineer. Alison Kwok joins the company in the capacity of Programme Manager from Owen Mumford where she held the post of Technical Project Manager for the past […]

Continue Reading

Oval signs two feasibility deals with pharmaceutical companies

11th April 2011 – Oval Medical Technologies Ltd., the company developing the next generation of autoinjector technology, announced today that they have entered into two deals with pharmaceutical companies who are putting Oval’s primary drug containment technology through feasibility trials. Oval’s CEO Matthew Young has said, ‘These two deals have been signed at a key […]

Continue Reading

Next generation autoinjector shows clear superiority

10th January 2011 – Oval Medical Technologies Ltd., the Cambridge based autoinjector company today announced results from two user studies in which Oval’s novel, proprietary autoinjector clearly demonstrated superiority compared with two well-known autoinjector devices currently on the market. The Oval next generation autoinjector is designed to be smaller, easier and safer to use than […]

Continue Reading

Oval Medical featured in ONdrugDELIVERY

Oval Medical Technologies Limited is based in Cambridge and has broad expertise in design and development of drug delivery devices focusing on vials, prefilled syringes and autoinjectors. The company was born out of what it saw as a need for radical innovation in the design of autoinjectors.

Continue Reading

Three new employees appointed

27th July 2010 – Today, Oval Medical is pleased to announce that the on-going success of developing its revolutionary autoinjector and syringe technologies, has lead to the company’s second expansion less than a year after the company was established.</p> As of July 2010, three new members have joined the team adopting a variety of roles […]

Continue Reading

Oval Medical signs a technology assessment contract with a pharmaceutical partner

February 12th, 2013 – Oval Medical Technologies Ltd.(“Oval”),  announces that it has signed a further technology assessment contract with a pharmaceutical partner. The drug under investigation is for the treatment of severe infections in patients with chronic lung disease and is expected to be self-injected in a clinical or home setting. The agreement includes a […]

Continue Reading